wikimedia
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Triples
Insights
Schema
BETA
Class frequency
Class hierarchy
SPARQL
Graphs
1
Q39257661-CEFEA5E1-C782-4F35-8FA8-C8C27FA42920
Q39257661-CEFEA5E1-C782-4F35-8FA8-C8C27FA42920
BestRank
Statement
http://www.wikidata.org/entity/statement/Q39257661-CEFEA5E1-C782-4F35-8FA8-C8C27FA42920
Randomized Phase II trial of nintedanib, afatinib and sequential combination in castration-resistant prostate cancer.
P2860
Q39257661-CEFEA5E1-C782-4F35-8FA8-C8C27FA42920
BestRank
Statement
http://www.wikidata.org/entity/statement/Q39257661-CEFEA5E1-C782-4F35-8FA8-C8C27FA42920
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
a99b9818c7e0951f561b751be2f5774161f238da
P2860
Epidermal growth factor receptor expression escapes androgen regulation in prostate cancer: a potential molecular switch for tumour growth.